Williams Laura A
Chief Patient Officer
Williams Laura A has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.
On the most recent filing, Williams Laura A is listed as Chief Patient Officer at ARDELYX, INC. Inside the rolling window, Williams Laura A reported no open-market purchases and 6 open-market sales totaling $1.0M in ARDX. The largest disclosed transaction in the window is a sale of 81,898 ARDX shares on Jun 18, 2026, worth $490K.
Companies traded
Other insiders at ARDX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Laura A made?
Williams Laura A has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Williams Laura A trade?
Williams Laura A has filed SEC Form 4 disclosures for 1 company, including ARDX.
When was Williams Laura A's most recent SEC Form 4 filing?
Williams Laura A's most recent SEC Form 4 filing on Tracefour is dated Aug 25, 2026.
What is Williams Laura A's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Williams Laura A is listed as Chief Patient Officer.
What is Williams Laura A's total buy and sell value in the current window?
Inside the rolling retention window, Williams Laura A bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Williams Laura A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 81,898 ARDX shares on 2026-06-18, worth $490K, per SEC Form 4 filings.